Published on
September 4, 2019
- 11:05 GMT
Orchard Therapeutics Announces Encouraging Update from Proof-of-Concept Study of OTL-203 for the Treatment of ...
Six of Eight Patients Treated to Date with Follow-up Out to 12 Months in First Patient to Receive Treatment Evidence of Engraftment and Peripheral Blood Alpha-L-iduronidase (IDUA) Enzyme Overexpression Across Cohort BOSTON and LONDON, Sept. 04, 2019 (GLOBE …
Distribution channels:
Healthcare & Pharmaceuticals Industry, Media, Advertising & PR
...
